Low-cost drug dexamethasone allowed for Covid-19 treatment in India

By / 3 days ago / News Update / No Comments
Low-cost drug dexamethasone allowed for Covid-19 treatment in India
The government has allowed the use of the low-cost steroid drug dexamethasone as an alternative to methylprednisolone to treat coronavirus patients with moderate and severe symptoms. This comes after WHO called for increase in dexamethasone production after UK clinical trials found it had life-saving potential for critically ill Covid-19 patients. It’s already used in treating lung infections.

Nitigya Sharma

The author didn't add any Information to his profile yet.

Leave a comment

Your email address will not be published. Required fields are marked. *